3 research outputs found
Clinically isolated syndrome: prognostic markers for conversion to multiple sclerosis and initiation of disease-modifying therapy
- Author
- Binquet C Quantin C, Le Teuff G, e
- Bjartmar C Trapp BD
- CHAMPIONS Study Group
- Comi G
- Dalton CM Brex PA, Jenkins R, et a
- DI FILIPPO M
- Eriksson M Andersen O, Runmarker B
- Fazekas F Offenbacher H, Fuchs S,
- Fisniku LK Chard DT, Jackson JS, e
- Frohman EM Goodin DS, Calabresi PA
- Frohman EM Havrdova E, Lublin F, e
- Goodin DS Frohman EM, Garmany GP J
- Jacobs LD Cookfair DL, Rudick RA,
- Kappos L Freedman MS, Polman CH, e
- Kappos L Freedman MS, Polman CH, e
- Kappos L Polman CH, Freedman MS, e
- Kappos L Traboulsee A, Constantine
- KOORIYAMA TATSUO
- Kurne A Isikay IC, Karlioguz K, et
- Lebrun C Bensa C, Debouverie M, et
- Masjuan J Alvarez-Cermeno JC, Garc
- Miller D Barkhof F, Montalban X, e
- Miller DH Weinshenker BG, Filippi
- Minneboo A Barkhof F, Polman CH, e
- O'Connor P Kinkel RP, Kremenc
- Okuda DT Mowry EM, Beheshtian A, e
- Optic Neuritis Study Group
- Paolillo A Piattella MC, Pantano P
- Paty DW Oger JJ, Kastrukoff LF, et
- Pittock SJ Weinshenker BG, Nosewor
- Secondary Progressive Efficacy Clin
- Swanton JK Fernando K, Dalton CM,
- Swanton JK Rovira A, Tintore M, et
- TANAKA MASAMI
- The IFNB Multiple Sclerosis Study G
- The IFNB Multiple Sclerosis Study G
- The Once Weekly Interferon for MS S
- Tintoré
- Tintoré
- Tintoré
- Tintore M Rovira A, Martinez MJ, e
- Wattjes MP Harzheim M, Lutterbey G
- Wattjes MP Harzheim M, Lutterbey G
- Publication venue
- 'Societas Neurologica Japonica'
- Publication date
- 01/01/2011
- Field of study
No full textInterferon-β treatment for multiple sclerosis
- Author
- A Bayas
- A Bertolotto
- A Ghezzi
- A Isaacs
- A Noronha
- B Banwell
- B Bielekova
- B Weinstock-Guttman
- BD Trapp
- Berlex Laboratories
- Biogen Idec
- C Bell
- C Gasperini
- C Papeix
- C Rask
- CF Lucchinetti
- CH Polman
- CJ Phillips
- CK Jones
- CL Karp
- D Pohl
- D Pohl
- DK Li
- DS Goodin
- E Fisher
- E Waubant
- EM Frohman
- European Study Group on Interferon Beta-1b in Secondary Progressive MS
- FD Lublin
- G Comi
- G Ebers
- G Kobelt
- GS Francis
- H Panitch
- H Panitch
- H Tremlett
- HF Petereit
- HL Tremlett
- HS Panitch
- IFNB Multiple Sclerosis Study Group
- IFNB Multiple Sclerosis Study Group
- J Alam
- J Chilcott
- J Killestein
- JA Cohen
- JA Cohen
- JA Frank
- JH Noseworthy
- JM Charcot
- K Biemacki
- K Whetten-Goldstein
- KP Wandinger
- L Durelli
- L Jacobs
- L Jacobs
- L Kappos
- L Kappos
- L Kappos
- LA Stone
- LD Jacobs
- LD Jacobs
- M Clanet
- M Filippi
- M Hardmeier
- M Trojano
- MA Siddiqui
- O Andersen
- P Perini
- PA Calabresi
- PA Neighbour
- PD Molyneux
- PK Coyle
- PRISMS (Prevention of Relapses and Disability by Interferon Beta-1a Subcutaneously in Multiple Sclerosis) Study Group
- PRISMS Study Group
- PS Sorensen
- RA Bermel
- RA Rudick
- RA Rudick
- RA Rudick
- RA Rudick
- Richard A. Rudick
- RM Ransohoff
- Robert A. Bermel
- RP Kinkel
- Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon-beta-1a in MS (SPECTRIMS) Study Group
- Serono
- SM Leary
- SN Tenembaum
- SR Schwid
- SR Schwid
- VW Yong
- VW Yong
- WI McDonald
- WW Tourtellotte
- Y Mikaeloff
- Y Warabi
- Publication venue
- 'Elsevier BV'
- Publication date
- Field of study
No full textDisease Modifying Agents in the Treatment of Multiple Sclerosis
- Author
- on behalf of the REGARD Study Group
- A Achiron
- A Coles
- A Ghezzi
- A Langer-Gould
- A Miravalle
- A Pestronk
- AA Schuna
- AD Goodman
- AE Warrington
- AJ Coles
- AJ Coles
- AL Sayao
- B Bielekova
- B Bielekova
- B Bielekova
- B Engelhardt
- B Weinstock-Guttman
- BA Cree
- BC Kieseier
- BD Trapp
- BD Trapp
- BG Weinshenker
- BK Kleinschmidt-DeMasters
- BN Becker
- BO Khatri
- BW Thrower
- C Caon
- C Farina
- C Ford
- C Polman
- C Pozzilli
- C Trebst
- CH Polman
- D Barnes
- D Cadavid
- D Mahad
- D Ridder De
- DE Goodkin
- DH Miller
- DK Li
- DR Smith
- DS Goodin
- DS Goodin
- DT Okuda
- DW Paty
- E Bernitsas
- E Fox
- EC Klawiter
- EM Frohman
- EU Walther
- European Study Group on interferon
- F Fazekas
- F Leypoldt
- G Assche Van
- G Birnbaum
- G Comi
- G Comi
- G Comi
- G Edan
- G Giovannoni
- G Hutas
- G Lus
- G Mancardi
- GP Rice
- GT Tran
- H Ehrenreich
- H Panitch
- H Panitch
- HC Lehmann
- HL Weiner
- HP Hartung
- HP Hartung
- J Goebel
- J Kovarsky
- J Seze de
- JA Cohen
- JA Cohen
- JA Cohen
- JA Frank
- JC Sipe
- JC Sipe
- JH Noseworthy
- JH Simon
- JM Flynn
- JR Berger
- JR Berger
- JT Chen
- JW Rose
- K Hoffmann
- K Khalili
- KG Su
- KP Johnson
- KP Johnson
- KR Carson
- KR Carson
- L Durelli
- L Gorelik
- L Kappos
- L Kappos
- L Kappos
- L Kappos
- L Kappos
- L Kappos
- L Kappos
- L Roccatagliata
- LD Jacobs
- LD Jacobs
- LK Fisniku
- LM Metz
- M Debouverie
- M Hutchinson
- M Inglese
- M Mehling
- M Pulicken
- MA Fanale
- MM Vellinga
- MS Freedman
- N Putzki
- N Stefano De
- NF Kalkers
- O Fernandez
- O Hommes
- O Neuhaus
- O Perier
- O Stuve
- O Stüve
- OA Khan
- P O’Connor
- P O’Connor
- P Patrikios
- P Sørensen
- P Vermersch
- PA Calabresi
- PL Yudkin
- PRISMS Study Group
- PRISMS Study Group
- PS Sorensen
- PW O’Connor
- PW O’Connor
- R Doorn Van
- R Ellis
- R Gold
- R Zivadinov
- RA Rudick
- RA Rudick
- RA Rudick
- RE Gonsette
- RP Kinkel
- S Cepok
- S Ferrero
- S Goffette
- S Llufriu
- S Markovic-Plese
- S Schilling
- SA Rizvi
- SC Sensken
- SG Waxman
- SL Hauser
- SM Alam
- SM Leary
- SN Liossis
- SPECTRIMS Study Group
- T Ishibashi
- T Kopadze
- T Tan
- T Vollmer
- TA Johnson
- TA Yousry
- The Canadian Cooperative Multiple Sclerosis Study Group
- The IFNB Multiple Sclerosis Study Group
- The IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group
- TJ Stillwell
- TW West
- V Brinkmann
- VW Yong
- VW Yong
- X Lin
- Y Qin
- Z Hl
- Publication venue
- 'Springer Science and Business Media LLC'
- Publication date
- Field of study
No full text
